Skip to main content
Premium Trial:

Request an Annual Quote

Agilent to Begin Selling its Microarray Products in India

NEW YORK, April 21 (GenomeWeb News) - Agilent Technologies will begin distributing its microarray products to India, expanding its life-sciences business efforts there from its sales base of chemical and pharmaceutical QA/QC equipment, the company said today.

The announcement follows the release for comment of India's draft biotechnology strategy earlier this month. In that strategy, India's government proposed establishing a National Biotechnology Regulatory Authority to oversee market clearance for all biotechnology products, and suggests that priority be given to research in molecular and cellular biology, neuroscience, molecular genetics, transplantation biology, genomics, proteomics, systems biology, RNA interference, and stem-cell research.

Agilent, which is considered by some observers to be the largest biotechnology equipment supplier in India, said the country's recent biotech positioning can fuel demand for molecular biology tools, including its microarrays.

"Growth in sectors like biopharmaceuticals, contract research bioservices, agriculture, genetic engineering, and molecular medicine will drive growth for analytical instrumentation," Sanjeev Dhar, who was named Agilent's India manager in January, said in a statement.

See BioCommerce Week, a GenomeWeb News publication, for an interview with Dhar and an article on India's molecular-biology tools market.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.